Public health messaging misses the mark on Monkeypox and HIV A cross‑jurisdiction survey of publicly available Monkeypox and HIV materials from state, large metropolitan and select non‑metro U.S. health departments…
Read More
Ten Years, One Live Celebration: Join the conversation We were proud to celebrate a remarkable milestone at ODAC 2026, held January 16-19, 2026. It was a fitting place to honor…
Read More
In skin of color, halo phenomena can mask benign lesions; biopsy and dermoscopic‑pathologic correlation remain essential It’s time to dive into one of our January JDD case reports ! A…
Read More
Barrier boost for acne care: A new gel moisturizer soothes, strengthens and lifts quality of life We’re highlighting a December 2025 article that features one of JDD’s most sought-after topics:…
Read More
Aesthetics Is Changing. Here’s What We’re Seeing? Most dermatologists have experienced a shift in patient preferences over the past several years. There is a shift toward a minimalist, natural appearance.…
Read More
Trials fall short on representation - Black patients underenrolled in MF/SS studies The February issue of JDD features a review of completed US interventional trials for mycosis fungoides and Sézary syndrome…
Read More
Case report shows dual IL‑17A/F blockade produced striking clinical and functional gains within one month in refractory ACH The February 2026 JDD issue features a case report about a 67‑year‑old…
Read More
Combined Relabotulinum Toxin A frontalis modulation with NASHA™ gel skinboosters for the temples yields natural‑looking wrinkle softening and lasting skin quality gains beyond six months The Oncoderm Resource Center on…
Read More
Medscape highlighted a January Journal of Drugs in Dermatology study on the incidence of skin and hair effects from GLP-1 agonists. The study, “Cutaneous Adverse Events Associated With GLP-1 Receptor…
Read More
Case report: six weeks of gentian violet and trichloroacetic acid peel produced marked healing in dominant dystrophic epidermolysis bullosa with minimal discomfort The February 2026 JDD issue features a case…
Read More
Combined Relabotulinum Toxin A frontalis modulation with NASHA™ gel skinboosters for the temples yields natural‑looking wrinkle softening and lasting skin quality gains beyond six months A preliminary clinical series tested…
Read More
From the Vault: Review of the last decade finds biological rationale for skin and hair benefits, yet no FDA approvals and major gaps in standardization and clinical data Dive into…
Read More
